Scandinavian Study Clears GLP-1 Agonists of Thyroid Cancer Risk
In a comprehensive study spanning three Scandinavian countries, researchers from the Karolinska Institute in Sweden have found no significant link between the use of GLP-1 analogues, a popular class of diabetes drugs, and an increased risk of thyroid cancer.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed